Clinical Data AACR 2026: Moderna, Revolution, Zymeworks and BeOne showcase new data BioSpaceModerna, Revolution Medicines and Zymeworks record wins in melanoma, lung and breast cancers, while BeOne swings and misses at head and neck cancer.Clinical DataRead full story pharminent April 21, 2026 (Last updated: April 21, 2026) BioSpace Moderna, Revolution Medicines and Zymeworks record wins in melanoma, lung and breast cancers, while BeOne swings and misses at head and neck cancer. Clinical DataRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: MSD, Eisai report setback in first-line kidney cancer trialNext: Novo Nordisk preps filings for sickle cell drug etavopivat Related Stories Clinical Data Parsortix study shows promise for ADC target detection pharminent August 3, 2026 Clinical Data Novo setback casts doubt on a new way to treat heart disease pharminent July 31, 2026 Clinical Data Altimmune rises as GLP-1/GIP drug curbs heavy drinking in mid-stage study pharminent July 28, 2026
